Allergan

How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
Motley Fool
Mon, 02/10/20 - 11:39 pm
Allergan
earnings
Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs
Fierce Biotech
Mon, 02/3/20 - 10:35 am
Aerie Pharmaceuticals
Allergan
Alcon
medical affairs
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
Fri, 01/31/20 - 12:14 pm
migraines
Eli Lilly
Reyvow
Allergan
Ubrelvy
Allergan, Merck KGaA and Sai Life Sciences Invest in New Global Manufacturing Facilities
BioSpace
Thu, 01/30/20 - 10:48 am
Allergan
Merck KGaA
Sai Life Sciences
drug manufacturing
Allergan unveils new Botox plant ahead of $63B AbbVie merger
Fierce Pharma
Tue, 01/28/20 - 12:02 pm
AbbVie
Allergan
Botox
Ireland
drug manufacturing
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Mon, 01/27/20 - 10:57 am
Allergan
AbbVie
AstraZeneca
M&A
Nestle
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
Fierce Pharma
Fri, 01/10/20 - 11:55 pm
AbbVie
Allergan
antitrust
M&A
brazikumab
Europe
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
M&A
AbbVie
Allergan
Astellas
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
AbbVie answers Allergan aesthetics worries with separate new unit
Fierce Pharma
Wed, 01/8/20 - 12:16 pm
AbbVie
Allergan
aesthetics
M&A
Allergan Aesthetics
Overview: CRISPR Technology Headed to Clinical Trials
BioSpace
Wed, 01/8/20 - 10:33 am
CRISPR
Editas Medicine
clinical trials
Allergan
LCA10
Should AbbVie break up Allergan? If it wants to make up for Humira, then yes, analyst says
Fierce Pharma
Tue, 01/7/20 - 10:49 pm
AbbVie
Allergan
M&A
Humira
Botox
In last-minute deal, Allergan forks over a hefty $300M to settle pay-for-delay dispute
Fierce Pharma
Mon, 01/6/20 - 11:32 pm
AbbVie
Allergan
M&A
pay-for-delay
Warner Chilcott
Watson Pharmaceuticals
Novartis, Merck and Allergan raise drug prices to start 2020, joining Big Pharma peers
Fierce Pharma
Mon, 01/6/20 - 10:46 am
drug pricing
Merck
Allergan
Novartis
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
Allergan scores year-end FDA nod for CGRP migraine med Ubrelvy, plans early 2020 launch
Fierce Pharma
Mon, 12/23/19 - 11:56 pm
Allergan
UIbrelvy
ubrogepant
FDA
migraines
CGRPs
Amgen, Allergan join Rituxan biosimilar challenge with FDA filing
Pharmaforum
Fri, 12/20/19 - 12:15 pm
Amgen
Allergan
biosimilar
Roche
Rituxan
After big M&A year, will pharma move away from massive deals in 2020?
Fierce Pharma
Mon, 12/16/19 - 10:29 pm
M&A
Sanofi
Merck
AbbVie
Allergan
Bristol-Myers Squibb
Celgene
FTC
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
Mon, 12/9/19 - 09:45 am
FDA
Amgen
Vascepa
Allergan
migraines
ubrogepant
Intra-Cellular Therapies
lumateperone
schizophrenia
Go or no go? Vascepa’s finale and Allergan's pain relief
EP Vantage
Mon, 12/2/19 - 10:37 am
FDA
Amarin
Vascepa
Allergan
migraines
ubrogepant
Before 2019 closes, the FDA has 3 key approval decisions to make
Biopharma Dive
Wed, 11/27/19 - 12:43 pm
Allergan
ubrogepant
migraines
Amarin
Vascepa
Intra-Cellular Therapeutics
lumateperone
schizophrenia
bipolar disorder
drug approvals
FDA

Pages